Literature DB >> 25540752

Quantification of corneal neovascularization after ex vivo limbal epithelial stem cell therapy.

Adriano Guarnieri1, Javier Moreno-Montañés1, Belén Alfonso-Bartolozzi1, Alfonso L Sabater1, María García-Guzmán2, Enrique J Andreu2, Felipe Prosper2.   

Abstract

AIM: To assess cultured limbal epithelial stem cell transplantation in patients with limbal stem cell deficiency by analyzing and quantifying corneal neovascularization.
METHODS: This retrospective, interventional case series included eight eyes with total limbal stem cell deficiency. Ex vivo limbal epithelial stem cells were cultured on human amniotic membrane using an animal-free culture method. The clinical parameters of limbal stem cell deficiency, impression cytology, and quantification of corneal neovascularization were evaluated before and after cultured limbal stem cell transplantation. The area of corneal neovascularization, vessel caliber (VC), and invasive area (IA) were analyzed before and after stem cell transplantation by image analysis software. Best-corrected visual acuity (BCVA), epithelial transparency, and impression cytology were also measured.
RESULTS: One year after surgery, successful cases showed a reduction (improvement) of all three parameters of corneal neovascularization [neovascular area (NA), VC, IA], while failed cases did not. NA decreased a mean of 32.31% (P=0.035), invasion area 29.37% (P=0.018) and VC 14.29% (P=0.072). BCVA improved in all eyes (mean follow-up, 76±21mo). Epithelial transparency improved significantly from 2.00±0.93 to 0.88±1.25 (P=0.014). Impression cytology showed that three cases failed after limbal epithelial stem cell therapy before 1y of follow-up.
CONCLUSION: This method of analyzing and monitoring surface vessels is useful for evaluating the epithelial status during follow-up, as successful cases showed a bigger reduction in corneal neovascularization parameters than failed cases. Using this method, successful cases could be differentiated from failed cases.

Entities:  

Keywords:  corneal neovascularization; impression cytology; limbal stem cell; limbal stem cell deficiency; stem cell therapy

Year:  2014        PMID: 25540752      PMCID: PMC4270994          DOI: 10.3980/j.issn.2222-3959.2014.06.14

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  21 in total

Review 1.  Limbal stem cells of the corneal epithelium.

Authors:  H S Dua; A Azuara-Blanco
Journal:  Surv Ophthalmol       Date:  2000 Mar-Apr       Impact factor: 6.048

Review 2.  Midterm results of cultivated autologous and allogeneic limbal epithelial transplantation in limbal stem cell deficiency.

Authors:  Mikk Pauklin; Thomas A Fuchsluger; Henrike Westekemper; Klaus-P Steuhl; Daniel Meller
Journal:  Dev Ophthalmol       Date:  2010-05-18

Review 3.  Amniotic membrane: from structure and functions to clinical applications.

Authors:  A C Mamede; M J Carvalho; A M Abrantes; M Laranjo; C J Maia; M F Botelho
Journal:  Cell Tissue Res       Date:  2012-05-18       Impact factor: 5.249

4.  Midterm results on ocular surface reconstruction using cultivated autologous oral mucosal epithelial transplantation.

Authors:  Tsutomu Inatomi; Takahiro Nakamura; Noriko Koizumi; Chie Sotozono; Norihiko Yokoi; Shigeru Kinoshita
Journal:  Am J Ophthalmol       Date:  2006-02       Impact factor: 5.258

5.  Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable.

Authors:  Claus Cursiefen; Joseph Colin; Reza Dana; Manuel Diaz-Llopis; Lana A Faraj; Salvador Garcia-Delpech; Gerd Geerling; Francis W Price; Lies Remeijer; Barry T Rouse; Berthold Seitz; Patricia Udaondo; Daniel Meller; Harminder Dua
Journal:  Br J Ophthalmol       Date:  2011-06-28       Impact factor: 4.638

Review 6.  New hopes and strategies for the treatment of severe ocular surface disease.

Authors:  Takahiro Nakamura; Shigeru Kinoshita
Journal:  Curr Opin Ophthalmol       Date:  2011-07       Impact factor: 3.761

7.  Analysis of limbal stem cell deficiency by corneal impression cytology.

Authors:  Pietro Maria Donisi; Paolo Rama; Adriano Fasolo; Diego Ponzin
Journal:  Cornea       Date:  2003-08       Impact factor: 2.651

Review 8.  Concise review: limbal stem cell deficiency, dysfunction, and distress.

Authors:  Sajjad Ahmad
Journal:  Stem Cells Transl Med       Date:  2012-01-26       Impact factor: 6.940

9.  Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium.

Authors:  G Pellegrini; C E Traverso; A T Franzi; M Zingirian; R Cancedda; M De Luca
Journal:  Lancet       Date:  1997-04-05       Impact factor: 79.321

Review 10.  Transplantation of ex vivo cultured limbal epithelial stem cells: a review of techniques and clinical results.

Authors:  Alex J Shortt; Genevieve A Secker; Maria D Notara; G Astrid Limb; Peng T Khaw; Stephen J Tuft; Julie T Daniels
Journal:  Surv Ophthalmol       Date:  2007 Sep-Oct       Impact factor: 6.048

View more
  3 in total

Review 1.  Current and emerging therapies for corneal neovascularization.

Authors:  Danial Roshandel; Medi Eslani; Alireza Baradaran-Rafii; Albert Y Cheung; Khaliq Kurji; Sayena Jabbehdari; Alejandra Maiz; Setareh Jalali; Ali R Djalilian; Edward J Holland
Journal:  Ocul Surf       Date:  2018-06-20       Impact factor: 5.033

Review 2.  Concise Review: Altered Versus Unaltered Amniotic Membrane as a Substrate for Limbal Epithelial Cells.

Authors:  Tor Paaske Utheim; Øygunn Aass Utheim; Panagiotis Salvanos; Catherine J Jackson; Stefan Schrader; Gerd Geerling; Amer Sehic
Journal:  Stem Cells Transl Med       Date:  2018-03-23       Impact factor: 6.940

3.  Comparison of Optical Coherence Tomography Angiography to Indocyanine Green Angiography and Slit Lamp Photography for Corneal Vascularization in an Animal Model.

Authors:  Tisha P Stanzel; Kavya Devarajan; Nyein C Lwin; Gary H Yam; Leopold Schmetterer; Jodhbir S Mehta; Marcus Ang
Journal:  Sci Rep       Date:  2018-07-31       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.